|

Dextromethorphan Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Stanford University1
  • Murdoch Childrens Research Institute1
  • AstraZeneca1

Indications

  • Cancer2
  • Illness Anxiety Disorder1
  • Body Dysmorphic Disorders1
  • Somatic Symptom Disorder1
  • Obsessive-compulsive Disorder1

Other2 trials

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Phase 1
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
Phase 1

Stanford, California1 trial

Study of Dextromethorphan in OCD and Related Disorders

Stanford University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.